Sale!

6-30 Plan

Your 30-Day Gut Health Starter Plan

Kickstart digestive balance with the Atrantil 6-30 Plan, then maintain results with continued daily use.

  • Targets the source of bloating
  • Rebalances Your Microbiome
  • Polyphenol-rich ingredients
  • Doctor-formulated and clinically studied

2 Bottles — $67.92  $79.90(Save 15%)

Purchase one time
$39.95
1 Bottle
You can earn points for purchasing this product.

Outside the US? Choose an option below!
Other international orders can be placed through Supplement Hub/Amrita Nutrition

What is the 6-30 Plan?

Take six carefully formulated capsules daily for 30 days. That’s it. The 6-30 plan was developed through 8 years of clinical observations. When even the toughest-to-treat patients took 6 capsules a day for 30 days, 88% found relief.

Proper dosing is critical; whether you take 2 capsules 3 times a day or 3 twice a day as a part of your regular supplementation, it is essential to take all 6. If you find relief faster than 30 days, you can switch to the maintenance dose of 2 capsules once a day.

Why Take the 6-30 Plan?

1

Targeted Relief:

Say goodbye to uncomfortable bloating, irregular bowel movements, and abdominal discomfort. The 6-30 Plan specifically targets the underlying causes of these issues, providing you with much-needed relief.

2

Rebalance Your Microbiome:

Your gut is home to trillions of bacteria that play a crucial role in your overall well-being. Sticking to the 6-30 Plan helps restore the balance of good and bad bacteria in your gut, promoting optimal digestion and absorption of nutrients.

3

Long-Term Results:

We believe in sustainable solutions. By committing to the 6-30 Plan, you’re investing in long-term gut health. The benefits you’ll experience during the program are just the beginning of a healthier future.

4

Expert Formulation:

Atrantil was created by a gastroenterologist and backed by years of scientific research and expertise. Our capsules are carefully crafted using natural ingredients that have been clinically studied for their gut health benefits.

What Can You Expect?

During your 30-day journey with the 6-30 Plan, you'll start noticing positive changes in your digestive health.

Alleviate Bloating & Abdominal Discomfort

Our product is the only natural, clinically proven method to help reduce bloating and ease digestive issues.

Prevent Changes in Bowel Movement

This patented blend of polyphenols works as a postbiotic to feed good bacteria and support overall digestive health. As a result, the reduction of methane-producing bacteria returns the upper GI tract to its normal nearly sterile condition and helps the digestive system to work the way it should without those unexpected and unwanted changes.

Improve Your Gut Health & Digestion

Atrantil has a super high antioxidant count and is full of beneficial polyphenols.

Attack The Problem at The Source

Atrantil gets rid of problem gas-producing bacteria that cause bloating and abdominal discomfort with or without constipation or diarrhea.

Ingredients

Made up of three polyphenols- Quebracho Colorado, Horse Chestnut, and Peppermint- Atrantil is backed by science and clinically proven.

The ingredients in Atrantil are non-GMO, tested, and held to the highest standards of purity. Atrantil is manufactured in the United States.

Atrantil is completely free of most allergens, including milk, eggs, peanuts, gluten, soy, and shellfish.

Visit https://atrantil.com/ingredients/ for more information.

Peppermint Leaf

Peppermint

A natural antispasmodic, Atrantil uses the whole leaf extract (not just oil) to briefly relax the small bowel which in turn allows Quebracho and Horse Chestnut to work more efficiently.

Quebracho

A natural and very complex polyphenol which soaks up the hydrogen (the fuel needed for methane production), and also binds to and disrupts the cell wall of the archaebacteria (this weakens and stresses the methane producer).

Horse Chestnut

A natural inhibitor to the enzyme that allows methane to be produced, this extract enters the archaebacteria cell through the disrupted cell wall and shuts down the methane-producing mechanism.

Dosing

Atrantil controls gas producing bacteria, returning the gut to its normal state and lets the digestive tract work the way it should.

*Individual results may vary

Clinical Trials

Northwestern Feinberg School of Medicine

Northwestern University Feinberg School of Medicine Study

This study demonstrated the most ideal test for any over the counter solution regarding health issues such as bloating or associated gastrointestinal methane problems. First, the results demonstrated that 56% of all participants experienced adequate relief. Those results were measured against SEVEN categories of suffering. Second, this was a 100% independent, major university medical school test constructed without bias. Third, essentially there were no exclusionary criteria for participants. These are serious parameters for any solution to meet a challenge and Atrantil more than met expectations. The integrity of the design was trusted to a worldwide recognized leader in gastroenterology, the Principal Investigator, Darren Brenner, MD, FACG, AGAF, RFF. Dr. Brenner is a professor of medicine and surgery, an IDP Foundation Research Scholar, and the director of the Northwestern University Neurophysiology Program.

None of KBS Research, LLC and all associated partners had any influence, monetary or otherwise, regarding the study design, product acquisition, or analysis of results.

Clinical Trials

88% of Patients Found Relief

Double-Blind Study

In a double-blind clinical study of patients suffering from bloating, constipation and abdominal discomfort, Atrantil proved to be more than 88 percent effective in relieving symptoms. The results of the study were published in the Journal of Gastroenterology and Hepatology Research – September 21, 2015 pp. 1762-1767.

Clinical Trials

80% Effective

Open-Label Study

The open-label study targeted the toughest-to-treat patients to illustrate the efficacy of Atrantil. Before beginning the study, patients qualified to participate only after failing to find relief from at least four other therapies. The trial showed that 80 percent of patients found relief after using Atrantil to control their bloating, constipation and abdominal discomfort. The results of the study were published in the World Journal of Gastrointestinal Pharmacology and Therapeutics – August 6, 2016 pp. 463-468.

>